LSBC -- Large Scale Biology Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LSBC -- Large Scale Biology Corp.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	9/23/2003 8:51:52 AM
From: nigel bates	Read Replies (1) of 144

GERMANTOWN, Md.--(BUSINESS WIRE)--Sept. 23, 2003--Large Scale Biology Corporation (Nasdaq:LSBC - News) has been awarded a grant by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for research leading to the discovery of biomarkers for alcohol-related diseases. Discovery of significant protein factors are expected to impact early diagnosis, monitoring and treatment of alcoholic diseases. The work will be conducted at LSBC's Proteomics Division. The study will generate a comprehensive database of changes in protein expression from different areas of the brain as induced by alcohol-related phenomena. LSBC's proprietary ProGEx(TM) protein expression technology will separate, quantify and identify proteins exhibiting significant correlations. The work will include collaboration with the Indiana University Alcohol Research Center, a specialized alcoholism research facility funded by NIAAA. "This proteomics study for NIAAA represents an application of LSBC technology in the vast and promising area of brain research," said Kevin J. Ryan, president and CEO of LSBC. "We are pleased by this opportunity to contribute to the mission of NIAAA and the global health implications of its focus." About Large Scale Biology Corporation Large Scale Biology is an integrated biotechnology company focusing on product development and biomanufacturing of protein and peptide therapeutics and vaccines. Corporate offices and R&D are headquartered in Vacaville, Calif.; the Company's Proteomics Division is located in Germantown, Md.; and the Company's Biomanufacturing Division is located in Owensboro, Ky. For more information about Large Scale Biology Corporation, visit the Company's Web site at www.lsbc.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next